Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1650 of 3546 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/12/09
End: 03/24/15
Due: 03/24/16
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 07/13/07
End: 05/03/10
Due: 05/03/11
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 10/08/12
End: 01/18/14
Due: 01/18/15
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 07/19/19
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 04/09/08
End: 01/08/10
Due: 01/08/11
Phase: N/A
Priority: Normal
Start: 02/21/11
End: 09/13/17
Due: 09/13/18
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 10/08/03
End: 12/16/04
Due: 12/16/05
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 12/28/06
End: 01/25/07
Due: 01/25/08
Phase: N/A
Priority: Normal
Start: 09/21/18
End: 07/22/20
Due: 07/22/21
Phase: N/A
Priority: Normal
Start: 09/10/09
End: 11/24/10
Due: 11/24/11
Phase: N/A
Priority: Normal
Start: 10/14/23
End: 07/08/24
Due: 07/08/25
Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis
Phase: N/A
Priority: Normal
Start: 06/15/16
End: 10/30/17
Due: 10/30/18
Phase: N/A
Priority: Normal
Start: 09/15/09
End: 01/10/13
Due: 01/10/14
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 11/30/12
Due: 11/30/13
Phase: N/A
Priority: Normal
Start: 01/14/06
End: 10/17/06
Due: 10/17/07
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 03/19/08
End: 03/18/11
Due: 03/18/12
Phase: N/A
Priority: Normal
Start: 06/30/98
End: 04/30/11
Due: 04/30/12